According to the Wall Street Journal on December 30, Iranian health ministry officials said that Iran launched a domestic human trial to develop a coronavirus vaccine on Tuesday.
According to the report, the vaccine is based on an inactivated novel coronavirus and will go through three clinical trial stages before it is approved by the Iranian authorities.
A total of 56 volunteers participated in the experiment. Officials said that all three phases are expected to be completed within 60 days.
It is reported that the vaccine was developed by a company affiliated with Imam Khomeini’s Command Executive Headquarters (EIKO), an economic and charitable organization controlled by the Office of the Supreme Leader of Iran.
Mohammad Mokhber, head of EIKO, said his organization will be able to produce nearly 1.5 million doses a month over the next two weeks, with the ultimate goal of producing 12 million doses a month over the next six months.
The first to participate in the experiment was Tayyebeh Mokhber, the daughter of the head of EIKO.
